RxDoctor Payments Data

Sarah Kantharia, MD

Vascular & Interventional Radiology · Washington, DCNPI 1881039253

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Boston Scientific at 27.1% of the total. Reporting peaked in 2022 at $1,761 and has fallen 82.5% since, to $308 in 2025.

$6,549in general payments, 2019–2025

Across 59 payments — averaging $110.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$2K
  • Inari Medical, Inc.$1K
  • Biocompatibles, Inc.$1K
  • Terumo Medical Corporation$336
  • Siemens Medical Solutions USA, Inc.$312
  • plus $85 from 2 others

What the payments were for

  • Travel & lodging$2,84143%
  • Food & beverage$3,70857%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,549 in reported general payments places this provider in the 65th percentile of 26 vascular & interventional radiology providers in District of Columbia.

See all vascular & interventional radiology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$50,817
Medicare patients
324
Services billed
3,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →